Verve Therapeutics, Inc. (VERV) Ownership

$11.13

north_east
$0.03 (0.27%)
Day's range
$11.13
Day's range
$11.13

Verve Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ALPHABET INC. 08/01/2025 12.17 M $136.65 M   -1.46% 13.70%
BLACKROCK, INC. 08/12/2025 7.36 M $82.62 M   -6.62% 8.29%
PENTWATER CAPITAL MANAGEMENT LP 08/14/2025 6.72 M $75.47 M   100.00% 7.57%
VANGUARD GROUP INC 08/11/2025 4.19 M $47.07 M   5.99% 4.72%
CASDIN CAPITAL, LLC 08/14/2025 4.10 M $45.99 M   2.50% 4.61%
FARALLON CAPITAL MANAGEMENT LLC 08/14/2025 3.61 M $40.56 M   296.05% 4.07%
ALPINE ASSOCIATES MANAGEMENT INC. 08/05/2025 2.74 M $30.75 M   100.00% 3.08%
STATE STREET CORP 08/14/2025 2.63 M $29.50 M   -15.02% 2.96%
HUDSON BAY CAPITAL MANAGEMENT LP 08/18/2025 2.10 M $23.53 M   100.00% 2.36%
ARCH VENTURE MANAGEMENT, LLC 08/14/2025 2.01 M $22.56 M   0.00% 2.26%
UBS GROUP AG 08/14/2025 1.87 M $21.01 M   1,319.50% 2.11%
HUDSON BAY CAPITAL MANAGEMENT LP 08/18/2025 1.75 M $19.63 M   100.00% 1.97%
GEODE CAPITAL MANAGEMENT, LLC 08/08/2025 1.70 M $19.14 M   1.31% 1.92%
BAKER BROS. ADVISORS LP 08/14/2025 1.69 M $19.00 M   0.00% 1.91%
NUVEEN, LLC 08/12/2025 1.61 M $18.10 M   21.68% 1.82%
JPMORGAN CHASE & CO 08/12/2025 1.14 M $12.82 M   261.16% 1.29%
RENAISSANCE TECHNOLOGIES LLC 08/13/2025 1.05 M $11.76 M   479.42% 1.18%
DIMENSIONAL FUND ADVISORS LP 08/12/2025 817.53 K $9.18 M   83.92% 0.92%
TWO SIGMA INVESTMENTS, LP 08/14/2025 812.36 K $9.12 M   114.01% 0.91%
REDMILE GROUP, LLC 08/14/2025 740.26 K $8.31 M   -38.68% 0.83%
NORDEA INVESTMENT MANAGEMENT AB 07/29/2025 675.85 K $7.62 M   100.00% 0.76%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/12/2025 592.44 K $6.65 M   4.27% 0.67%
NORTHERN TRUST CORP 08/13/2025 588.83 K $6.61 M   -5.23% 0.66%
BNP PARIBAS ARBITRAGE, SNC 08/14/2025 566.20 K $6.36 M   9,951.55% 0.64%
WEISS ASSET MANAGEMENT LP 08/14/2025 538.42 K $6.05 M   100.00% 0.61%
BANK OF AMERICA CORP /DE/ 08/14/2025 485.80 K $5.46 M   -70.25% 0.55%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2025 469.02 K $5.27 M   100.00% 0.53%
TWO SIGMA ADVISERS, LP 08/14/2025 381.30 K $4.28 M   119.39% 0.43%
OMERS ADMINISTRATION CORP 08/13/2025 371.20 K $4.17 M   100.00% 0.42%
WATER ISLAND CAPITAL LLC 08/14/2025 335.59 K $3.77 M   100.00% 0.38%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/14/2025 331.44 K $3.72 M   100.00% 0.37%
GABELLI & CO INVESTMENT ADVISERS, INC. 08/13/2025 302.40 K $3.40 M   100.00% 0.34%
BARCLAYS PLC 08/14/2025 301.60 K $3.39 M   61.31% 0.34%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2025 298.69 K $3.35 M   22.32% 0.34%
GABELLI FUNDS LLC 08/13/2025 267.52 K $3.00 M   100.00% 0.30%
TREXQUANT INVESTMENT LP 08/12/2025 229.78 K $2.58 M   -60.95% 0.26%
CSS LLC/IL 08/14/2025 223.60 K $2.51 M   100.00% 0.25%
BANK OF NEW YORK MELLON CORP 08/05/2025 220.79 K $2.48 M   -1.89% 0.25%
AQR ARBITRAGE LLC 08/14/2025 208.70 K $2.34 M   100.00% 0.24%
JANE STREET GROUP, LLC 08/14/2025 198.66 K $2.23 M   97.21% 0.22%
UBS ASSET MANAGEMENT AMERICAS INC 08/14/2025 183.61 K $2.06 M   37.47% 0.21%
CITIGROUP INC 08/11/2025 176.56 K $1.98 M   25.33% 0.20%
SCHONFELD STRATEGIC ADVISORS LLC 08/14/2025 176.28 K $1.98 M   -93.97% 0.20%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 170.20 K $1.91 M   134.44% 0.19%
AMERICAN CENTURY COMPANIES INC 08/12/2025 169.17 K $1.90 M   12.12% 0.19%
INVESCO LTD. 08/13/2025 143.45 K $1.61 M   68.05% 0.16%
MILLENNIUM MANAGEMENT LLC 08/14/2025 138.22 K $1.55 M   -93.45% 0.16%
CHICAGO CAPITAL MANAGEMENT, LLC 08/07/2025 125.38 K $1.41 M   100.00% 0.14%
FIDUCIARY TRUST CO 08/14/2025 120.00 K $1.35 M   50.00% 0.14%
JEFFERIES FINANCIAL GROUP INC. 08/12/2025 116.90 K $1.31 M   100.00% 0.13%

Verve Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 175 institutional investors and hedge funds held shares of Verve Therapeutics, Inc.. The most heavily invested institutionals were:

UBS Group AG: 0

ProShare Advisors LLC: 0

INTECH INVESTMENT MANAGEMENT LLC: 0

XTX Topco Ltd: 0

OMERS ADMINISTRATION Corp: 0

WELLS FARGO & COMPANY/MN: 0

79.30% of Verve Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 8.28 M shares in the last 24 months. This purchase volume represents approximately $92.18 M in transactions.